Literature DB >> 29856080

New-onset epilepsy in the elderly.

Lily Chi Vu1, Loretta Piccenna2, Patrick Kwan1,2, Terence J O'Brien1,2.   

Abstract

People who are 60 years old and older have the highest incidence of developing new-onset epilepsy. The increase of the ageing population has resulted in a greater number of patients with new-onset epilepsy or at risk of developing the condition. Previously published review articles regarding epilepsy in older patients have had a broad focus, including people who were diagnosed with epilepsy in their childhood or middle age. The present review focuses on the causes, treatment, prognosis and psychosocial impact of new-onset epilepsy in people aged ≥60 years. Following a search of the medical electronic databases and relevant references, we identified 22 studies overall that met the inclusion criteria. Only four randomized clinical trials (RCTs) were identified that compared different antiepileptic drug treatments in this population, demonstrating that newer-generation antiepileptic drugs (e.g. lamotrigine and levetiracetam) were generally better tolerated. One uncontrolled study provided promising evidence of good outcomes and safety for surgical resection as a treatment for people with uncontrolled seizures. Five studies reported that people ≥60 years with new-onset epilepsy have significant cognitive impairments (e.g. memory loss) and psychological issues including depression, anxiety and fatigue. We found that there is limited evidence to guide treatment in people with Alzheimer's disease and epilepsy. The specific features of new-onset epilepsy in this target population significantly influences the choice of treatment. Cognitive and psychiatric screening before treatment may be useful for management. Two studies with proposed guidelines were identified but no formal clinical practice guidelines exist for this special population to assist with appropriate management. There is a need for more RCTs that investigate effective treatments with limited side effects. More research studies on the psychosocial effects of new-onset epilepsy, and long-term outcomes, for people aged ≥60 years are also required.
© 2018 The British Pharmacological Society.

Entities:  

Keywords:  antiepileptic drugs; elderly; new-onset epilepsy; psychosocial; randomized controlled trials; treatment

Mesh:

Substances:

Year:  2018        PMID: 29856080      PMCID: PMC6138506          DOI: 10.1111/bcp.13653

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  56 in total

Review 1.  Epilepsy in elderly people.

Authors:  Martin J Brodie; Patrick Kwan
Journal:  BMJ       Date:  2005-12-03

2.  The impact of epilepsy on health status among younger and older adults.

Authors:  Mary Jo V Pugh; Laurel A Copeland; John E Zeber; Joyce A Cramer; Megan E Amuan; Jose E Cavazos; Lewis E Kazis
Journal:  Epilepsia       Date:  2005-11       Impact factor: 5.864

3.  First seizure in the older patient: clinical features and prognosis.

Authors:  Nicholas Lawn; Andrew Kelly; John Dunne; Judy Lee; Andrew Wesseldine
Journal:  Epilepsy Res       Date:  2013-09-02       Impact factor: 3.045

4.  A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy.

Authors:  Konrad J Werhahn; Eugen Trinka; Judith Dobesberger; Iris Unterberger; Petra Baum; Maria Deckert-Schmitz; Tobias Kniess; Bettina Schmitz; Viviane Bernedo; Christian Ruckes; Anne Ehrlich; Günter Krämer
Journal:  Epilepsia       Date:  2015-02-12       Impact factor: 5.864

5.  Falls and fractures in patients chronically treated with antiepileptic drugs.

Authors:  Baemisla Shiek Ahmad; Keith David Hill; Terence John O'Brien; Alexandra Gorelik; Natalie Habib; John Dennis Wark
Journal:  Neurology       Date:  2012-06-13       Impact factor: 9.910

6.  Outcomes in elderly patients with newly diagnosed and treated epilepsy.

Authors:  Martin J Brodie; Linda J Stephen
Journal:  Int Rev Neurobiol       Date:  2007       Impact factor: 3.230

Review 7.  Anti-epileptic medication and bone health.

Authors:  S J Petty; T J O'Brien; J D Wark
Journal:  Osteoporos Int       Date:  2006-11-08       Impact factor: 4.507

8.  Outcome of initial antiepileptic drug treatment in elderly patients with newly diagnosed epilepsy.

Authors:  Emmi Bruun; Reetta Kälviäinen; Tapani Keränen
Journal:  Epilepsy Res       Date:  2016-08-20       Impact factor: 3.045

9.  Prevalence of epilepsy in Rochester, Minnesota: 1940-1980.

Authors:  W A Hauser; J F Annegers; L T Kurland
Journal:  Epilepsia       Date:  1991 Jul-Aug       Impact factor: 5.864

10.  Psychiatric and medical admissions observed among elderly patients with new-onset epilepsy.

Authors:  Laurel A Copeland; Alan B Ettinger; John E Zeber; Jodi M Gonzalez; Mary Jo Pugh
Journal:  BMC Health Serv Res       Date:  2011-04-19       Impact factor: 2.655

View more
  11 in total

1.  Treatment of Seizures in Older Patients with Dementia.

Authors:  Benjamin Cretin
Journal:  Drugs Aging       Date:  2020-12-14       Impact factor: 3.923

Review 2.  N6-methyladenosine and Neurological Diseases.

Authors:  Nan Zhang; Chunhong Ding; Yuxin Zuo; Yu Peng; Lielian Zuo
Journal:  Mol Neurobiol       Date:  2022-01-15       Impact factor: 5.590

3.  Changes in the Use of Brand Name and Generic Medications and Total Prescription Cost Among Medicare Beneficiaries With Epilepsy.

Authors:  Samuel Waller Terman; Chun C Lin; Wesley T Kerr; Lindsey B DeLott; Brian C Callaghan; James F Burke
Journal:  Neurology       Date:  2022-06-15       Impact factor: 11.800

4.  Decreased synapse-associated proteins are associated with the onset of epileptic memory impairment in endothelial CDK5-deficient mice.

Authors:  Zheng-Mao Li; Xiu-Xiu Liu; Chen Li; Zhao-Cong Wei; Yi Shi; Heng-Yi Song; Xiang Chen; Yu Zhang; Jia-Wei Li; Rui-Fang Zhu; Ben-Hui Hu; Wei-Feng Ye; Da Huo; Guo-Jun Jiang; Takuya Sasaki; Li Zhang; Feng Han; Ying-Mei Lu
Journal:  MedComm (2020)       Date:  2022-06-20

5.  Association of Alzheimer's Disease with the Risk of Developing Epilepsy: a 10-Year Nationwide Cohort Study.

Authors:  Hyun Ji Lyou; Kwon-Duk Seo; Ji Eun Lee; Hae Yong Pak; Jun Hong Lee
Journal:  Dement Neurocogn Disord       Date:  2019-01-23

6.  Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study.

Authors:  Charlotte Lawthom; Pedro Bermejo; Dulce Campos; Rob McMurray; Vicente Villanueva
Journal:  Neurol Ther       Date:  2019-05-16

7.  A European Academy of Neurology guideline on medical management issues in dementia.

Authors:  K S Frederiksen; C Cooper; G B Frisoni; L Frölich; J Georges; M G Kramberger; C Nilsson; P Passmore; L Mantoan Ritter; D Religa; R Schmidt; E Stefanova; A Verdelho; M Vandenbulcke; B Winblad; G Waldemar
Journal:  Eur J Neurol       Date:  2020-07-26       Impact factor: 6.089

8.  Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update.

Authors:  Susana Ferrao Santos; Anna C Jansen; Lieven Lagae; Benjamin Legros; Sarah Weckhuysen; Paul Boon
Journal:  Acta Neurol Belg       Date:  2020-10-13       Impact factor: 2.396

9.  Investigating the molecular mechanism of Compound Danshen Dropping Pills for the treatment of epilepsy by utilizing network pharmacology and molecular docking technology.

Authors:  Dan Huang; Xiaolong Wen; Chuansen Lu; Bo Zhang; Zongjun Fu; Yingliu Huang; Kun Niu; Fan Yang
Journal:  Ann Transl Med       Date:  2022-02

10.  Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy.

Authors:  Samuel W Terman; Brett E Youngerman; Hyunmi Choi; James F Burke
Journal:  Epilepsia       Date:  2022-03-25       Impact factor: 6.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.